History

History

2010-Memorabilia

BEIJING CANNY CONSULTING INC.

Your trustworthy consultant for food and drug regulatory compliance!

  • 2014
    • August

      The CANNY•Taizhou•China Medical City Office was officially listed.

    • August

      Kanglihua's shareholding company, Taizhou Jinlihua Purification Engineering Co., Ltd., was formally established.

    • July

      Beijing. Kanglihua and Regenold GmbH jointly hosted the “European Drug Registration and Market Development Seminar”.

    • June

      Kanglihua customer Zhejiang Meinuohua Pharmaceutical Chemical Co., Ltd. successfully passed the official Slovenian GMP audit of the European Union. This is the first successful case that Conohua completed to help domestic companies pass the official Slovenian audit.

    • May

      Kanglihua customer Wuhan Yuanda Hongyuan Co., Ltd. passed the FDA on-site inspection. This is the sixth case of Conley's customer who passed the FDA on-site inspection with “zero defect”.

    • May

      Chengdu. Kanglihua and Sinopharm Reed Exhibition Co., Ltd. jointly hosted the “2014 API CHINA Foreign Trade Forum”.

    • May

      Kanglihua officially became a holding subsidiary of Tiger Pharmaceuticals (stock code: 300347.SZ).

  • 2013
    • December

      Mr. Kang Pengcheng, the chief consultant of Kanglihua, first proposed the concept of “CRAO” in the industry.

    • November

      Dr. Stefan Kettelhoit, General Manager of Blue Inspection Body, Germany, and Ralf Sibbing, General Manager of Diapharm, Germany, came to visit.

    • November

      The “Construction Internationalization Development Capacity Building Seminar” hosted by E-Pharmaceuticals Magazine and hosted by Beijing Kanglihua Consulting Services Co., Ltd. was held in Beijing.

    • September

      After the joint efforts of Kanglihua and Tangshan Sanxin Biochemical Products Co., Ltd., Tangshan Sanxin Biochemical Chondroitin Sulfate Products obtained CEP (TSE category) certificate.

    • August

      Conley Consulting has added a “US NDI Application” business.

    • August

      Dr. Zhang Wei from the Danish Investment Promotion Agency visited Conley Consulting to jointly promote the Chinese pharmaceutical companies and Chinese medical and health products into the Danish/European market, promote the cooperation between Conley Consulting and the Danish related registration/CRO institutions, and jointly carry out international registration certification training. Cooperation intention.

    • August

      Kanglihua customer Dongying Tiandong Pharmaceutical Co., Ltd. passed the FDA on-site inspection. This is the fifth case of Conley's fifth-pass FDA on-site inspection.

    • August

      Kanglihua Consulting was invited by the Jinan Food and Drug Administration to provide support for the new GMP training for the “Jinan City Third Drug GMP Training Course”.

    • June

      Vice President Xu Ming of the China Chamber of Commerce for Import and Export of Medicines and Health Products, and Zhang Zhongpeng, deputy director of the Technical Service Center, visited Kanglihua for guidance and guidance.

    • April

      During the 69th National Drug Fair, Kanglihua Consulting held the “Study on the Conformity Evaluation and GMP Certification Site Inspection”.

    • April

      Conley Consulting has added a “general drug quality consistency evaluation” business.

    • March

      After the joint efforts of Kanglihua and Xinjiang Xinziyuan Pharmaceutical Co., Ltd., Xinjiang Xinziyuan Pregnancy Horse Estrogen Products obtained CEP certificate, which is the first EDQM approved estrogen CEP certificate.

    • February

      Conley Consulting has added the “CFDA On-site Inspection of Overseas Enterprises” business.

  • 2012
    • December

      The inaugural issue of Conley's Inner Journal was published.

    • November

      The new version of Kanglihua Consulting official website was officially launched.

    • October

      Organized by the International Pharmaceutical Inspection Association (PIC/S) and the International Intestinal Sterile Pharmaceutical Association (PDA), the “Pharmaceutical GMP (ICH Q7) Seminar” hosted by Beijing Kanglihua Consulting Services Co., Ltd. was held in Beijing.

    • September

      Kanglihua and China Medical International Exchange Center jointly hosted the “China New GMP Implementation and European and American GMP Inspection Key Points Seminar” in Beijing.

    • May

      Kanglihua customer Hubei Guangji Pharmaceutical Co., Ltd. accepted FDA on-site inspection of dietary supplements and successfully passed the inspection with “zero defects”. This is Kanglihua's fourth customer who passed the FDA on-site inspection with “zero defects”.

    • April

      Kang Lihua participated in the 67th National Drug Trade Fair held in Hefei, Anhui Province, and co-hosted the “New GMP Implementation and Corporate Response Strategy Seminar” with Sinopharm Reed Exhibition.

    • March

      Kanglihua customer Shandong Shouguang Fukang Pharmaceutical Co., Ltd. accepted the GMP on-site inspection of EDQM and successfully passed the official inspection with the assistance of Conley.

    • April

      Ms. Virginie Morin, Manager of International Development Department of CROFTHAWK Consulting, France, and her delegation visited Kanglihua to discuss cooperation in the South American and European markets. This cooperation will open up new channels for our company to further expand the international registration and certification business of pharmaceutical products.

  • 2011
    • November

      After the joint efforts of Kanglihua and Xinjiang Xinziyuan Pharmaceutical Co., Ltd., Xinjiang Xinziyuan Pregnancy Horse Estrogen Products obtained the US DMF file number, which is the first DMF file in China to file the pregnancy-horse combined estrogen products in the FDA.

    • October

      Kanglihua customer Zhejiang Rongyao Chemical Co., Ltd. "Zero Defect" successfully passed the FDA on-site inspection. This is Kanglihua's third customer who passed the FDA on-site inspection with “zero defects”.

    • September

      Kanglihua customer Jilin Liaoyuan Yinying Pharmaceutical Co., Ltd. successfully passed the FDA on-site inspection.

  • 2010
    • September

      Kanglihua customer Nanning Evonik Meishi Pharmaceutical Co., Ltd. passed the FDA on-site inspection. Nanning Evonik is a wholly-owned subsidiary of the world's top 500 companies, Evonik Industries Group (formerly Degussa Group).

    • July

      Kanglihua successfully obtained the archive number for the “Dye Packaging Aluminum Foil” DMF file produced by Jiangsu Zhongjin Matai Pharmaceutical Packaging Materials Co., Ltd. This is the first time that China's domestic medicinal aluminum foil packaging materials have successfully archived DMF documents in the US FDA. Established a regulatory basis for the US market. This is another domestic first in the field of pharmaceutical packaging registration with Kanglihua and customers!

    • June

      In Kanglihua customer Zhejiang Kangyu Pharmaceutical Co., Ltd. received an FDA review and the inspection passed smoothly.

    • June

      Kanglihua was successfully commissioned by the Dutch consulting company DaDa Consultancy B.V. to conduct a third-party audit of Tianjin Tianyao Pharmaceutical Co., Ltd.

    • June

      Kanglihua was successfully commissioned by the Dutch consulting company DaDa Consultancy B.V. to conduct a third-party audit of Wuhan Yuanda Pharmaceutical Group Co., Ltd.

    • April

      Kanglihua customer Shandong Luye Pharmaceutical Co., Ltd. successfully passed the Australian TGA certification review.